With the completion of the Human Genome Project, human medicine is entering a new era. A large wave of outstanding medical breakthroughs and financial investments will lead a new era of personalized precision medicine .
"Every patient is unique. Doctors are always doing everything they can to get medicine. Just like you have to transfuse blood, blood types must match. This is a very important finding. If we take the individual's genetic code with Cancer is "matched" and as a practical standard, we decide that the dose of the drug will be as convenient as measuring our body temperature - this is the hope that precision medicine brings us."
- Obama, 2015. 1. 20
In his 2015 State of the Union address, US President Barack Obama announced that the United States will invest $215 million to launch a program called Precision Medicine (PM), which will bring precision medicine into the public as a national strategy. Vision.
The so-called precision medical treatment is a new medical model based on the individual information of patients. In this mode, medical decision-making, implementation, etc. are formulated according to the individualized characteristics of patients. The diagnosis and treatment of diseases is also the integration of genetic information in patients with big data information such as their individual environment, lifestyle and health history. Based on the basis.
Opening a new era of medical miracles
a big problem that is booming, but slow progress in precision medicine
Pioneer of timeline precision medicine
Case study genetic data globalization
The era of Q&A "medical selfie" is coming soon
Big problem research and capital gamble
Case study large-scale manufacturing of DNA era will come early
Medical miracle of the new era
Newborn babies should enjoy the beauty of the new world without worry, but not every baby is so lucky.
On July 25, 2015, Carina came to the world with countless newborns with loud crying, but a small lump on her chin was doomed to her fate.
Initially the doctor did not diagnose it, but then found it to be a malignant tumor. Carina, who is only one and a half years old, has received eight rounds of chemotherapy and surgery.
In the face of once again unstoppable growth of stubborn tumors, Karena’s parents are struggling to do anything. Radiation therapy may help, but its damage to the brain makes this a new parent.
The doctor advised them to try any possible test drug.
Genetic testing of tumors revealed that Karina had abnormal fusion of two gene sequences leading to tumors. Carina's oncologist, Ramamoorthy, found a clinical trial drug that can interfere with the synthesis of proteins synthesized by such genes, but the drug is currently only for adults.
Subsequently, Dr. Rama Moses and drug manufacturer Loxo Oncology applied to the US FDA for a clinical trial of children. In December last year, Carina became the first patient to participate.
The tumor was initially as large as a walnut, and after 28 days of treatment, the tumor was almost completely gone. Although Carina will continue to take the drug, the tumor may change again and come back, but now Carina is a lively and lovely two-year-old child.
Carina’s father gratefully said: This treatment has made our family happy again.
The success of Carina and other similar cases is due to precision medicine.
Oat Powder is produced by the specific enzymatic hydrolysis and spray drying technology, so it is called Hydrolyzed oat powder or Enzymolysis Oat Powder. It has a pleasant oat fragrance with creamy mouthfeel and smooth texture. It retains all the soluble nutrients of oats, such as high-quality plant protein, fat, soluble dietary fiber(3-glucan>3%). It is high-viscosity and slightly sweet, easy to digest and absorb. It is stable and good resistance to acid and heat treatment after dissolution in water.
Oat Powder,Oat Milk Powder,Hydrolyzed Oat Flour,Hydrolyzed Oat Powder,Enzymolysis Oat Powder
Xi'an Gawen Biotechnology Co., Ltd , https://www.amulyn-bio.com